The Latest Breaking News from PFE

Despite rampant market volatility, Goldman Sachs expects the U.S. economy to avoid a recession. However, as uncertainties remain, medical stocks Pfizer (PFE) and Bristol-Myers Squibb (BMY), which pay reliable dividends, could be ideal buys to ensure a steady income stream. Keep reading….

Amid rising global medical needs, the pharmaceutical industry is expected to witness robust growth in the coming years. Moreover, healthcare is considered relatively resilient amid market downturns. So, given the economic uncertainties, investors could consider buying quality pharmaceutical stocks such as Pfizer (PFE), Novartis (NVS), and Bristol-Myers Squibb (BMY) this…

Amid the stock market chaos due to the Fed’s fight against inflation and recessionary concerns, dividend stocks are gaining traction. Fundamentally strong dividend stocks can provide protection and ensure stable income. So, high-yield dividend stocks Pfizer (PFE), BHP Group (BHP), and Caledonia Mining (CMCL), with significant upside potential, might be…

Pfizer (PFE) has been a COVID beneficiary and is expected to continue to gain from its vaccines as the pandemic war is yet to be over. Moreover, PFE offers a more than 3% dividend. Thus, investors might consider buying this quality stock which seems well-positioned to weather any recession. Keep…

Covid cases continue to get registered to date, and the Biden administration is attempting to allocate more funding to address the pandemic. While investors should consider buying quality COVID-19 stock Pfizer (PFE), we think Teladoc Health (TDOC) might be best avoided now, considering its weak fundamentals. Keep reading….

With festive spending keeping the economy resilient despite the threat of interest rate hikes, it could be wise to invest in Pfizer (PFE), Broadcom (AVGO), and Restaurants Brands International (QSR) to give your portfolios a touch of holiday spirit. Continue reading….

Despite rampant economic headwinds, the U.S. job market remains tight and resilient. Although the uncertainties remain, investors should stay invested and focus on their long-term strategies. Therefore, quality stocks Pfizer (PFE) and Agilent Technologies (A) could be ideal picks to build a healthy portfolio for the long term. Keep reading….

Easing inflation and the Fed’s indication of slowing the pace of interest rate hikes are raising investors’ sentiments. Moreover, the November job report came in better than expected. While uncertainties remain, we think quality stocks Pfizer (PFE), AstraZeneca PLC (AZN), Carrier Global (CARR), J. Jill (JILL), and Lifeway Foods (LWAY)…

Despite rampant market volatility ahead of the November jobs data, and possible recession fears, experts believe the U.S. economy is resilient enough to handle a potential growth slowdown. Given the possibility of a year-end rally, quality stocks Pfizer (PFE) and AT&T (T) could now be ideal additions to your portfolio.…